Pallett SC, Jones R, Randell P, Davies GW, Moore LSP. Structured serological testing is an essential component to investigating SARS-CoV-2 reinfection. Lancet Infect Dis 2021; published online Jan 20. https://doi.org/10.1016/S1473-3099(20)30990-7—This Correspondence was published without copyright information. This correction has been made to the online version as of Feb 15, 2021, and will be made to the printed version.
. 2021 Feb 15;21(4):e81. doi: 10.1016/S1473-3099(21)00096-7
Correction to Lancet Infect Dis 2021; published online Jan 20. https://doi.org/10.1016/S1473-3099(20)30990-7
Issue date 2021 Apr.
Crown Copyright © 2021 Published by Elsevier Ltd. All rights reserved.
Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
PMCID: PMC8445260 PMID: 33600758
This corrects the article "Structured serological testing is an essential component to investigating SARS-CoV-2 reinfection" on page 598.